CPRX
Catalyst Pharmaceuticals Inc
$14.99
Earnings Summary
Revenue | $110.57Mn |
Net Profits | $34.84Mn |
Net Profit Margins | 31.51% |
Highlights
Catalyst Pharmaceuticals Inc’s revenue jumped 81.98% since last year same period to $110.57Mn in the Q4 2023. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 7.67% jump in its revenue since last 3-months.
Catalyst Pharmaceuticals Inc’s net profit jumped 36.8% since last year same period to $34.84Mn in the Q4 2023. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 213.26% jump in its net profits since last 3-months.
Catalyst Pharmaceuticals Inc’s net profit margin fell -24.83% since last year same period to 31.51% in the Q4 2023. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 205.19% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Catalyst Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.17 |
EPS Estimate Current Year | 0.17 |
Highlights
Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a -34.62% fall from last quarter’s estimates.
Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.17.
Key Ratios
Key ratios of the Catalyst Pharmaceuticals Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.31 |
Highlights
Catalyst Pharmaceuticals Inc’s earning per share (EPS) jumped 40.91% since last year same period to 0.31 in the Q4 2023. This indicates that the Catalyst Pharmaceuticals Inc has generated 40.91% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-28 | 0.26 | 0.31 | 19.23% |
2023-11-08 | -0.28 | -0.29 | -3.57% |
2023-05-10 | 0.32 | 0.26 | -18.75% |
2023-08-09 | 0.42 | 0.53 | 26.19% |
₹0 US Stocks a/c Opening Fee